
PRA Health Sciences, Inc. – NASDAQ:PRAH
PRA Health Sciences stock price today
PRA Health Sciences stock price monthly change
PRA Health Sciences stock price quarterly change
PRA Health Sciences stock price yearly change
PRA Health Sciences key metrics
Market Cap | 1 |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 3.35 |
Revenue | 3.33B |
EBITDA | 444.89M |
Income | 213.32M |
Revenue Q/Q | 19.14% |
Revenue Y/Y | 6.56% |
Profit margin | 6.4% |
Oper. margin | 8.69% |
Gross margin | 27.12% |
EBIT margin | 8.69% |
EBITDA margin | 13.35% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePRA Health Sciences stock price history
PRA Health Sciences stock forecast
PRA Health Sciences financial statements
Jun 2020 | 729.89M | 13.87M | 1.9% |
---|---|---|---|
Sep 2020 | 796.30M | 91.25M | 11.46% |
Dec 2020 | 873.45M | 51.25M | 5.87% |
Mar 2021 | 933.77M | 56.94M | 6.1% |
2020-08-06 | 0.83 | 0.86 |
---|---|---|
2020-11-04 | 1.12 | 1.3 |
2021-02-24 | 1.47 | 1.55 |
2021-04-28 | 1.34 | 1.35 |
Jun 2020 | 3722801000 | 2.55B | 68.64% |
---|---|---|---|
Sep 2020 | 3839214000 | 2.51B | 65.48% |
Dec 2020 | 4178501000 | 2.69B | 64.6% |
Mar 2021 | 4282745000 | 2.72B | 63.66% |
Jun 2020 | 25.88M | -19.53M | 9.42M |
---|---|---|---|
Sep 2020 | 180.63M | -18.40M | 4.90M |
Dec 2020 | 160.07M | -14.66M | 21.90M |
Mar 2021 | 192.20M | -18.73M | 12.04M |
PRA Health Sciences other data
Period | Buy | Sel |
---|---|---|
Aug 2020 | 0 | 9489 |
Dec 2020 | 0 | 33372 |
Jan 2021 | 0 | 3136 |
Apr 2021 | 0 | 2048 |
Jun 2021 | 0 | 1638541 |
Patent |
---|
Application Filling date: 14 Jul 2020 Issue date: 7 Jan 2021 |
Quarter | Transcript |
---|---|
Q3 2020 7 Nov 2020 | Q3 2020 Earnings Call Transcript |
Q2 2020 7 Aug 2020 | Q2 2020 Earnings Call Transcript |
Q1 2020 1 May 2020 | Q1 2020 Earnings Call Transcript |
Q4 2019 21 Feb 2020 | Q4 2019 Earnings Call Transcript |
-
What's the price of PRA Health Sciences stock today?
One share of PRA Health Sciences stock can currently be purchased for approximately $165.21.
-
When is PRA Health Sciences's next earnings date?
Unfortunately, PRA Health Sciences's (PRAH) next earnings date is currently unknown.
-
Does PRA Health Sciences pay dividends?
No, PRA Health Sciences does not pay dividends.
-
How much money does PRA Health Sciences make?
PRA Health Sciences has a market capitalization of 1 and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.82% to 3.18B US dollars. PRA Health Sciences earned 197.04M US dollars in net income (profit) last year or $1.35 on an earnings per share basis.
-
What is PRA Health Sciences's stock symbol?
PRA Health Sciences, Inc. is traded on the NASDAQ under the ticker symbol "PRAH".
-
What is PRA Health Sciences's primary industry?
Company operates in the Healthcare sector and Diagnostics & Research industry.
-
How do i buy shares of PRA Health Sciences?
Shares of PRA Health Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does PRA Health Sciences have?
PRA Health Sciences, Inc. employs 18,100 workers.
-
When PRA Health Sciences went public?
PRA Health Sciences, Inc. is publicly traded company for more then 10 years since IPO on 13 Nov 2014.
-
What is PRA Health Sciences's official website?
The official website for PRA Health Sciences is prahs.com.
-
Where are PRA Health Sciences's headquarters?
PRA Health Sciences is headquartered at 4130 Parklake Ave Ste 400, Raleigh, NORTH CAROLINA.
-
How can i contact PRA Health Sciences?
PRA Health Sciences's mailing address is 4130 Parklake Ave Ste 400, Raleigh, NORTH CAROLINA and company can be reached via phone at +1 919 786 8200.
PRA Health Sciences company profile:

PRA Health Sciences, Inc.
prahs.comNASDAQ
18,100
Diagnostics & Research
Healthcare
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company has a partnership with The Leukemia & Lymphoma Society to launch a clinical trial for developing treatments for children with relapsed acute leukemia. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.
Raleigh, NORTH CAROLINA 27612
CIK: 0001613859
ISIN: US69354M1080
CUSIP: 69354M108